tiprankstipranks
Trending News
More News >
HQL
Tekla Life Sciences Investors of Benef Interest
Advertisement

HQL Technical Analysis

Summary of all the Indicators

Summary
Sell
7Bullish
5Neutral
10Bearish
Oscillators
Neutral
3Bullish
5Neutral
2Bearish
Moving Averages
Sell
4Bullish
0Neutral
8Bearish
Tekla Life Sciences Investors of Benef Interest’s (HQL) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Tekla Life Sciences Investors of Benef Interest is a Buy.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 20-Day exponential moving average is 16.82, making it a Sell.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 50-Day exponential moving average is 16.63, making it a Sell.

Tekla Life Sciences Investors of Benef Interest (HQL) Pivot Points

Jan 20, 2026, 12:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.05
16.33
16.46
16.74
16.87
17.15
17.28
Fibonacci
16.33
16.48
16.58
16.74
16.89
16.99
17.15

Tekla Life Sciences Investors of Benef Interest (HQL) Moving Averages

Jan 20, 2026, 12:05 AM
Period
Simple
Exponential
MA5
16.70Sell
16.69Sell
MA10
16.75Sell
16.75Sell
MA20
16.86Sell
16.82Sell
MA50
16.81Sell
16.63Sell
MA100
15.87Buy
15.86Buy
MA200
13.86Buy
14.34Buy
Tekla Life Sciences Investors of Benef Interest’s (HQL) 10-Day exponential moving average is 16.75, making it a Sell.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 100-Day exponential moving average is 15.86, making it a Buy.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 50-day simple moving average is 16.81, creating a Sell signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 100-day simple moving average is 15.87, creating a Buy signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 200-day simple moving average is 13.86, creating a Buy signal.

Tekla Life Sciences Investors of Benef Interest (HQL) Technical Analysis

Jan 20, 2026, 12:05 AM
Name
Value
Action
RSI (14)
45.05
Neutral
STOCH (9,6)
41.78
Neutral
STOCHRSI (14)
45.51
Neutral
MACD (12,26)
-0.05
Buy
ADX (14)
15.94
Buy
Williams %R
-59.65
Buy
CCI (14)
-80.11
Neutral
ATR (14)
0.38
-
Ultimate Oscillator
42.69
Neutral
ROC
-3.60
Sell
Tekla Life Sciences Investors of Benef Interest’s (HQL) Relative Strength Index (RSI) is 45.05, creating a Neutral signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) Trend Strength Indicator (ADX) is 15.94, creating a Buy signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) Commodity Channel Index (CCI) is -80.11, creating a Neutral signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) Price Rate of Change (ROC) is -3.60, creating a Sell signal.

FAQ

Is HQL a Buy, Hold, or Sell?
Based on HQL’s technical indicators, HQL is a Sell.
    What is HQL’s RSI (14)?
    HQL’s RSI (14) is 45.05, which suggests HQL is a Neutral.
      What is HQL’s MACD?
      HQL’s MACD is -0.05, which suggests HQL is a Buy.
        What is HQL’s 5-day moving average?
        HQL’s 5-day moving average is 16.70, which suggests HQL is a Sell.
          What is HQL’s 20-day moving average?
          HQL 20-day moving average is 16.86, which suggests HQL is a Sell.
            What is HQL’s 50-day moving average?
            HQL’s 50-day moving average is 16.81, which suggests HQL is a Sell.
              What is HQL’s 200-day moving average?
              HQL’s 200-day moving average is 13.86, which suggests HQL is a Buy.
                What is HQL’s Williams % R (14)?
                HQL’s Williams % R (14) is -59.65, which suggests HQL is a Buy.
                  What is HQL’s CCI (14)?
                  HQL’s CCI (14) is -80.11, which suggests HQL is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement